Valuation: BioNTech SE

Market Cap 2.51TCr 2.93TCr 2.35TCr 2.15TCr 4.03TCr 2,80200Cr 4.09TCr 28TCr 11TCr 1,40700Cr 11TCr 11TCr 4,65500Cr P/E 2026 *
-18.1x
P/E 2027 * -19.2x
Enterprise Value 1.37TCr 1.6TCr 1.28TCr 1.17TCr 2.2TCr 1,53200Cr 2.23TCr 15TCr 5.91TCr 77TCr 6.01TCr 5.88TCr 2,54500Cr EV / Sales 2026 *
7.59x
EV / Sales 2027 * 8.17x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+5.12%
1 week+25.22%
Current month+28.69%
1 month+26.94%
3 months+26.51%
6 months+5.83%
Current year+22.45%
1 week 91.01
Extreme 91.01
120.33
1 month 88.2
Extreme 88.2
120.33
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
379.98
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

1,927 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+5.12%+25.22%+5.13%-5.86% 2.93TCr
-3.00%+2.27%+73.26%+109.90% 7.21TCr
+1.90%+23.53%+59.48%+94.82% 6.59TCr
+0.55%+1.64%-4.63%+480.92% 2.75TCr
+2.74%+12.98%+54.92%+25.77% 2.67TCr
+0.47%+6.12%+37.01%-15.31% 2.01TCr
+1.82%-6.67%+251.36%+388.91% 1.82TCr
+0.94%+3.36%+15.30%+548.19% 1.64TCr
+0.73%+5.54%+39.99%+151.77% 1.34TCr
-0.41%+0.54%+308.39%+206.94% 1.23TCr
Average +1.09%+7.59%+84.02%+198.60% 3.02TCr
Weighted average by Cap. +0.69%+9.12%+68.23%+159.86%

Financials

2026 *2027 *
Net sales 180.71Cr 210.96Cr 169.08Cr 154.78Cr 290.47Cr 20TCr 294.31Cr 2TCr 779.03Cr 10TCr 792.13Cr 774.89Cr 34TCr 184.35Cr 215.21Cr 172.49Cr 157.9Cr 296.33Cr 21TCr 300.24Cr 2.04TCr 794.73Cr 10TCr 808.09Cr 790.51Cr 34TCr
Net income -134.84Cr -157.41Cr -126.16Cr -115.49Cr -216.74Cr -15TCr -219.6Cr -1.49TCr -581.28Cr -7.57TCr -591.06Cr -578.2Cr -25TCr -131.32Cr -153.3Cr -122.87Cr -112.47Cr -211.08Cr -15TCr -213.87Cr -1.45TCr -566.1Cr -7.37TCr -575.62Cr -563.1Cr -24TCr
Net Debt -1.14TCr -1.33TCr -1.06TCr -973.72Cr -1.83TCr -1,27000Cr -1.85TCr -13TCr -4.9TCr -64TCr -4.98TCr -4.87TCr -2,11000Cr -1TCr -1.17TCr -938.57Cr -859.15Cr -1.61TCr -1,12000Cr -1.63TCr -11TCr -4.32TCr -56TCr -4.4TCr -4.3TCr -1,86200Cr
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
21/26/21 $116.57 +5.12% 29,60,787
20/26/20 $110.89 -1.97% 35,34,286
19/26/19 $113.12 +21.96% 87,80,347
18/26/18 $92.75 +1.26% 9,21,586
17/26/17 $91.60 -1.60% 4,43,531
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
99.85EUR
Average target price
104.04EUR
Spread / Average Target
+4.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock